Allergies News and Research

Latest Allergies News and Research

CDC Director signs decision memo allowing Novavax monovalent COVID-19 boosters for adults

Today, CDC's Director Rochelle P. Walensky, M.D., M.P.H., signed a decision memo allowing Novavax monovalent COVID-19 boosters for adults.

24 Oct 2022

Dog ownership during infancy might attenuate the risk of persistent wheezing

In a new study, researchers examined the gene-environment (GxE) interactions between pet ownership in infancy and the 17q12-21 (asthma-risk) locus concerning wheezing.

24 Oct 2022

Three-dose regimen of HEPLISAV-B vaccine fully protects people living with HIV, data shows

The AIDS Clinical Trials Group (ACTG), the world's largest HIV research network whose focus has expanded to include evaluating outpatient treatment for COVID-19, today presented a session demonstrating that a three-dose regimen of the HEPLISAV-B vaccine fully protected people living with HIV at IDWeek 2022, taking place in Washington D.C. from October 19-22, 2022.

20 Oct 2022

Three-dose course of the hepatitis B vaccine fully protects adults living with HIV

A three-dose course of the hepatitis B vaccine HEPLISAV-B fully protected adults living with HIV who had never been vaccinated against or infected with the hepatitis B virus (HBV), according to study findings presented today at the IDWeek conference in Washington, D.C.

20 Oct 2022

Mass General Brigham sites announce participation in phase 3 trial of monkeypox treatment

Massachusetts General Hospital and Brigham and Women's Hospital, the founding members of Mass General Brigham, today announced their participation in STOMP (Study of Tecovirimat for Human Monkeypox Virus), a phase 3, randomized, placebo-controlled, double-blind trial evaluating the safety and efficacy of tecovirimat (TPOXX) for the treatment of human monkeypox.

19 Oct 2022

Does skin inflammation exacerbate COVID-19?

In a new study, researchers discussed inflammation during infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

18 Oct 2022

Danish researchers take an important step in finding a cure for HIV

For around 40 years, scientists all over the world have been unsuccessfully trying to find a cure for HIV, but now a team of researchers from Aarhus University and Aarhus University Hospital have apparently found an important element in the equation.

17 Oct 2022

Study links chemical composition of fine particulate air pollution to worse lung disease outcomes

People with a disease characterized by lung scarring that has no obvious cause are more likely to die if they live in areas with higher levels of air pollution composed of chemicals associated with industrial sources and vehicular traffic, according to new research led by University of Pittsburgh scientists.

17 Oct 2022

Selective immunoglobulin A deficiency a risk factor for severe COVID-19

In a recent study published in The Journal of Allergy and Clinical Immunology, researchers in New Zealand gathered evidence to show that selective immunoglobulin A deficiency (sIgAD) is an understated risk factor for severe coronavirus disease 2019 (COVID-19).

17 Oct 2022

Advances in nasal delivery of antibiotics

In a recent study published in the Journal of Drug Delivery Science and Technology, researchers reviewed the advances and challenges in the intranasal delivery of antibiotics.

17 Oct 2022

Study illuminates how pain neurons protect the gut from damage

Pain has been long recognized as one of evolution's most reliable tools to detect the presence of harm and signal that something is wrong - an alert system that tells us to pause and pay attention to our bodies.

14 Oct 2022

Study reveals why viral infections are less frequent but more severe in individuals with Down syndrome

Individuals with Down syndrome have less-frequent viral infections, but when present, these infections lead to more severe disease.

14 Oct 2022

HIV patients with moderate immune suppression at greater risk of severe COVID-19 "breakthrough" infection

People with HIV who have moderate immune suppression appear to be at greater risk of severe COVID-19 "breakthrough" infection after vaccination, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health.

13 Oct 2022

Clinical trial to evaluate antiviral drug for monkeypox begins in the Democratic Republic of the Congo

A clinical trial to evaluate the antiviral drug tecovirimat, also known as TPOXX, in adults and children with monkeypox has begun in the Democratic Republic of the Congo (DRC).

12 Oct 2022

Clinical trial to test the safety, efficacy of bacteriophages for treating P. aeruginosa infections in CF patients

Cystic fibrosis (CF) is an inherited disorder that causes severe damage to the lungs and other organs in the body.

11 Oct 2022

Cat allergen immunotherapy works better and more quickly when combined with monoclonal antibody

An experimental approach to enhancing a standard cat allergy treatment made it more effective and faster acting, and the benefits persisted for a year after treatment ended, a study supported by the National Institutes of Health has found.

11 Oct 2022

Duke receives federal funding for HIV vaccine research

The Duke Human Vaccine Institute and the Department of Surgery at Duke University School of Medicine received a grant from the National Institute of Allergy and Infectious Diseases for HIV vaccine research that could total $25.9 million with full funding over five years.

11 Oct 2022

Allergies News and Research

Latest Allergies News and Research

CDC Director signs decision memo allowing Novavax monovalent COVID-19 boosters for adults

Dog ownership during infancy might attenuate the risk of persistent wheezing

Three-dose regimen of HEPLISAV-B vaccine fully protects people living with HIV, data shows

Three-dose course of the hepatitis B vaccine fully protects adults living with HIV

Mass General Brigham sites announce participation in phase 3 trial of monkeypox treatment

Does skin inflammation exacerbate COVID-19?

Danish researchers take an important step in finding a cure for HIV

Study links chemical composition of fine particulate air pollution to worse lung disease outcomes

Selective immunoglobulin A deficiency a risk factor for severe COVID-19

Advances in nasal delivery of antibiotics

Study illuminates how pain neurons protect the gut from damage

Study reveals why viral infections are less frequent but more severe in individuals with Down syndrome

HIV patients with moderate immune suppression at greater risk of severe COVID-19 "breakthrough" infection

Clinical trial to evaluate antiviral drug for monkeypox begins in the Democratic Republic of the Congo

Clinical trial to test the safety, efficacy of bacteriophages for treating P. aeruginosa infections in CF patients

Cat allergen immunotherapy works better and more quickly when combined with monoclonal antibody

Duke receives federal funding for HIV vaccine research

New class of drugs can safely counter allergic asthma without creating vulnerability to infections

UMSOM researchers identify how multiple genes of SARS-CoV-2 affect disease severity

Simple new symptom-based screening tool detects asthma risk in young children

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Allergies News and Research

Latest Allergies News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in